With reference to previous reports (26) on adiponectin, we hypothesized that AdipoRaMab counteracts insulin resistance by improving insulin sensitivity and investigated the plasma glucose–lowering effect of AdipoRaMab in an insulin tolerance test (ITT). The gene discussed is ADIPOQ; the disease is Insulin resistance.